Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Preferred Shares (2021 - 2025)

Bioregenx has reported Preferred Shares over the past 5 years, most recently at $4.0 for Q4 2025.

  • For Q4 2025, Preferred Shares changed 0.0% year-over-year to $4.0; the TTM value through Dec 2025 reached $4.0, changed 0.0%, while the annual FY2025 figure was $4.0, 0.0% changed from the prior year.
  • Preferred Shares for Q4 2025 was $4.0 at Bioregenx, roughly flat from $4.0 in the prior quarter.
  • Over five years, Preferred Shares peaked at $5000.0 in Q4 2022 and troughed at $4.0 in Q4 2023.
  • A 5-year average of $1781.1 and a median of $4.0 in 2023 define the central range for Preferred Shares.
  • Biggest five-year swings in Preferred Shares: rose 2.04% in 2022 and later tumbled 99.92% in 2023.
  • Year by year, Preferred Shares stood at $4900.0 in 2021, then rose by 2.04% to $5000.0 in 2022, then plummeted by 99.92% to $4.0 in 2023, then changed by 0.0% to $4.0 in 2024, then changed by 0.0% to $4.0 in 2025.
  • Business Quant data shows Preferred Shares for BRGX at $4.0 in Q4 2025, $4.0 in Q3 2025, and $4.0 in Q2 2025.